首页> 美国卫生研究院文献>other >Tumor Suppression by MEG3 lncRNA in a Human Pituitary Tumor Derived Cell Line
【2h】

Tumor Suppression by MEG3 lncRNA in a Human Pituitary Tumor Derived Cell Line

机译:MEG3 lncRNA在人垂体肿瘤衍生细胞系中的肿瘤抑制。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human clinically non-functioning pituitary adenomas (NFAs) account for approximately 40% of diagnosed pituitary tumors. Epigenetic mutations in tumor suppressive genes play an important role in NFA development. Maternally expressed gene 3 (MEG3) is a long non-coding RNA (lncRNA) and we hypothesized that it is a candidate tumor suppressor whose epigenetic silencing is specifically linked to NFA development. In this study, we introduced MEG3 expression into PDFS cells, derived from a human NFA, using both inducible and constitutively active expression systems. MEG3 expression significantly suppressed xenograft tumor growth in vivo in nude mice. When induced in culture, MEG3 caused cell cycle arrest at the G1 phase. In addition, inactivation of p53 completely abolished tumor suppression by MEG3, indicating that MEG3 tumor suppression is mediated by p53. In conclusion, our data support the hypothesis that MEG3 is a lncRNA tumor suppressor in the pituitary and its inactivation contributes to NFA development.
机译:人类临床上无功能的垂体腺瘤(NFA)约占诊断出的垂体肿瘤的40%。肿瘤抑制基因中的表观遗传突变在NFA的发展中起重要作用。母体表达的基因3(MEG3)是一个长的非编码RNA(lncRNA),我们假设它是候选的抑癌基因,其表观遗传沉默与NFA的发育密切相关。在这项研究中,我们使用诱导型和组成型活性表达系统将MEG3表达引入了源自人NFA的PDFS细胞中。 MEG3表达显着抑制了裸鼠体内异种移植瘤的生长。当在培养中诱导时,MEG3导致细胞周期停滞在G1期。此外,p53的失活完全消除了MEG3对肿瘤的抑制作用,表明MEG3肿瘤抑制作用是由p53介导的。总之,我们的数据支持以下假设:MEG3是垂体中的lncRNA肿瘤抑制因子,其失活有助于NFA的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号